• Thumbnail for Bristol Myers Squibb
    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton...
    91 KB (7,411 words) - 12:29, 22 March 2024
  • Between 1977 and 2006, the Bristol-Myers Squibb Foundation presented annual awards of US$50,000 to scientists for distinguished achievements in fields...
    9 KB (124 words) - 00:50, 5 February 2024
  • Thumbnail for The Bristol-Myers Squibb Children's Hospital
    The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 105-bed pediatric acute care children's...
    37 KB (2,625 words) - 15:56, 13 August 2023
  • Thumbnail for John Ripley Myers
    as Bristol-Myers Squibb. Bristol-Myers Squibb is one of the largest pharmaceutical companies in the world. Myers' stepmother, Mary Ware Hewitt Myers (1848–1942)...
    7 KB (721 words) - 03:50, 21 June 2023
  • William McLaren Bristol (28 July 1860 – 1935) was one of the two co-founders of Bristol-Myers, now part of Bristol-Myers Squibb. Myers and Bristol founded the...
    2 KB (158 words) - 06:30, 24 May 2022
  • "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF). "Bristol Myers Squibb Q4 2022 Results" (PDF). "Bristol Myers...
    61 KB (2,701 words) - 11:52, 23 April 2024
  • growth was delayed by approximately 4.1 months. In September 2001, Bristol-Myers Squibb committed $2 billion (including a $1 billion up-front cash payment)...
    20 KB (2,186 words) - 05:02, 3 April 2023
  • Thumbnail for ZymoGenetics
    ZymoGenetics (category Bristol Myers Squibb)
    Eastlake Avenue East. It was closed in 2019 after its acquisition by Bristol Myers Squibb. The company was founded in 1981 by Professors Earl W. Davie and...
    13 KB (809 words) - 22:55, 22 January 2024
  • treatment. In June 2022, Owkin entered a strategic alliance with Bristol-Myers Squibb to help them design potentially more precise and efficient clinical...
    21 KB (1,802 words) - 00:07, 22 March 2024
  • Thumbnail for Deucravacitinib
    Deucravacitinib (category Drugs developed by Bristol Myers Squibb)
    2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb. Deucravacitinib was approved for medical use in the United States...
    12 KB (693 words) - 01:33, 19 April 2024